Evidence map›Paper›PMID 22720063›Full record

ArticlePloS one2012

Structure of an engineered β-lactamase maltose binding protein fusion protein: insights into heterotropic allosteric regulation.

Wei Ke, Abigail H Laurent, Morgan D Armstrong, Yuchao Chen, William E Smith, Jing Liang, Chapman M Wright, Marc Ostermeier, Focco van den Akker

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Simple mechanisms for the evolution of protein complexity.Protein science : a publication of the Protein Society · 2022
    Review
  2. Article
  3. Engineering Allostery into Proteins.Advances in experimental medicine and biology · 2019
    Review
  4. Article
  5. Article
  6. The interplay between effector binding and allostery in an engineered protein switch.Protein science : a publication of the Protein Society · 2016
    Article
  7. Article
  8. Article
  9. Engineering allosteric control to an unregulated enzyme by transfer of a regulatory domain.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wei KeDepartments of Biochemistry, Case Western Reserve University, Cleveland, Ohio, United States of America.
Abigail H Laurent
Morgan D Armstrong
Yuchao Chen
William E Smith
Jing Liang
Chapman M Wright
Marc Ostermeier
Focco van den Akker
Johns Hopkins University · USCase Western Reserve University · US

Funding

Case Center for Synchrotron BiosciencesP30EB009998 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI CHANCE, MARK R · 2009 to 2018
$8.4M
The Combinatorial Design of Protein Molecular SwitchesR01GM066972 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI OSTERMEIER, MARC A · 2003 to 2016
$4.0M
Mechanistic studies and inhibition strategies for antibiotic resistanceR01AI062968 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI VAN DEN AKKER, FOCCO · 2007 to 2010
$1.1M
NIAID NIH HHS R01 AI062968NIBIB NIH HHS P30 EB009998NIGMS NIH HHS R01 GM066972
6 · The paper itself

Abstract

Engineering novel allostery into existing proteins is a challenging endeavor to obtain novel sensors, therapeutic proteins, or modulate metabolic and cellular processes. The RG13 protein achieves such allostery by inserting a circularly permuted TEM-1 β-lactamase gene into the maltose binding protein (MBP). RG13 is positively regulated by maltose yet is, serendipitously, inhibited by Zn(2+) at low µM concentration. To probe the structure and allostery of RG13, we crystallized RG13 in the presence of mM Zn(2+) concentration and determined its structure. The structure reveals that the MBP and TEM-1 domains are in close proximity connected via two linkers and a zinc ion bridging both domains. By bridging both TEM-1 and MBP, Zn(2+) acts to "twist tie" the linkers thereby partially dislodging a linker between the two domains from its original catalytically productive position in TEM-1. This linker 1 contains residues normally part of the TEM-1 active site including the critical β3 and β4 strands important for activity. Mutagenesis of residues comprising the crystallographically observed Zn(2+) site only slightly affected Zn(2+) inhibition 2- to 4-fold. Combined with previous mutagenesis results we therefore hypothesize the presence of two or more inter-domain mutually exclusive inhibitory Zn(2+) sites. Mutagenesis and molecular modeling of an intact TEM-1 domain near MBP within the RG13 framework indicated a close surface proximity of the two domains with maltose switching being critically dependent on MBP linker anchoring residues and linker length. Structural analysis indicated that the linker attachment sites on MBP are at a site that, upon maltose binding, harbors both the largest local Cα distance changes and displays surface curvature changes, from concave to relatively flat becoming thus less sterically intrusive. Maltose activation and zinc inhibition of RG13 are hypothesized to have opposite effects on productive relaxation of the TEM-1 β3 linker region via steric and/or linker juxtapositioning mechanisms.

Indexed as

Protein EngineeringAllosteric Regulationbeta-LactamasesMaltose-Binding ProteinsModels, MolecularProtein Conformationbeta-LactamasesMaltose-Binding Proteins

Identifiers

PMID22720063
PMCPMC3375305
OpenAlexW1964294046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.